ERAL1 and endometrial cancer: For example, we formerly reported that abnormal phosphorylation of S518 in hERα is indispensable for the regulation of target gene expression in breast and endometrial cancer cells, as well as for endometrial cancer progression such as cell proliferation and migration [36–38].